This California town tops the most expensive rental market in the nation for third year running
In the Santa Cruz area, located on the Central Coast about 75 miles south of San Francisco, the hourly pay needed to afford a modest two-bedroom has risen from $63.33 in 2023 to $81.21 in 2025, according to the National Low-Income Housing Coalition's 2025 Out of Reach report.
This is up nearly 30% since 2023, when they were first put at the top of the list.
That means a renter must now earn $168,920 a year to be able to afford a modest two-bedroom at fair market rent in the metro area, the report shows. That would be a max of $4,223 a month in rent to stay under 30% of their gross income. In California, where the minimum wage is $16.50, that's the equivalent of working 4.9 full-time jobs.Billionaire In-n-out Heiress Lynsi Snyder And Family Leaving California For Tennessee
The report finds that the typical renter doesn't come close. The average renter in Santa Cruz County earns $22.13 an hour. At that rate, it would take about 3.7 full-time jobs to afford an apartment."This is a No. 1 we don't want to be," said Elaine Johnson, executive director of Housing Santa Cruz County to the Santa Cruz Sentinel. "This is an all-hands-on-deck kind of time for everyone involved."California state dominates affordability rankings, according to the Out of Reach report. The Golden State is home to eight of the ten most expensive metro areas, including San Jose, San Francisco, Salinas, and Santa Barbara. Statewide, the average housing wage for a two-bedroom apartment is nearly $50 per hour, which is the highest of any U.S. state. Timeline Of California's Yearslong And 'Disastrously Overpriced' High-speed Rail Project
At the current minimum wage, a full-time California worker would need to put in 120 hours a week to afford the average two-bedroom apartment. According to the report, "Nowhere in the United States—no state, metropolitan area, or county—can a full-time minimum-wage worker afford a modest two-bedroom rental home."The report attributes the problem to a severe and persistent supply shortage, estimating a national gap of 7.1 million affordable rental homes for extremely low-income or 'ELI' households.Critics say California's housing market is also hindered by overlapping layers of regulation."CEQA[California Environmental Quality Act] and restrictive zoning regulations are key contributors to California's housing shortage," said Dr. Wayne Winegarden, senior fellow at the Pacific Research Institute. "Prevailing wage mandates coupled with expensive environmental mandates... further inflates housing costs."
Read On The Fox Business App
Santa Cruz County Republican Party Chair Mike Lelieur told FOX Business the affordability crisis is a direct result of decades of progressive policy. "The local planning department has made it so outrageously expensive to build that it's just not profitable unless you're backed by a big corporate developer," Lelieur said. "Then you add CEQA, coastal commission reviews, endless permit delays, and greenbelt restrictions. It's a bureaucratic blockade by design."
He also criticized the University of California, Santa Cruz, for expanding its student population faster than it builds housing. "UCSC keeps expanding, but they're not building dorms fast enough. So students flood the local market and landlords jack up rents — because mom and dad are paying the bill," he said.Get Fox Business On The Go"This is a housing crisis created by policy," Lelieur said. "And unless we change course, it's only going to get worse."The Santa Cruz Beach Boardwalk and the Santa Cruz County Business Council did not immediately respond to FOX Business' request for comment.The full report can be found at https://nlihc.org/oorOriginal article source: This California town tops the most expensive rental market in the nation for third year running
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Intel earnings, Paramount-Skydance deal, Tesla rises
Here are some of the stories Wall Street is watching on Friday, July 25. Shares of Intel (INTC) are falling after posting a Q2 loss, though revenue topped estimates. The FCC has approved the $8 billion merger between Paramount (PARA, PARAA) and Skydance. Tesla (TSLA) shares are rising on a Business Insider report that the company plans to launch its robotaxi service in San Francisco this weekend. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute. It's time for Yahoo! Finance's market minute. Stocks are higher today as the major averages look to close out a strong week of gains amid earnings and trade updates. The S&P 500 now closing out its 13th record high in Thursday's trading session. Meanwhile, Intel shares are falling today after the chipmaker said it would slash founder costs and its latest attempt to turn around its struggling business. Concerns about where that leaves Intel's chip business and manufacturing overshadowed by a better than expected earnings report. Plus, Paramount and Skydance's $8 billion deal has been approved by the FCC. The deal, which was announced more than a year ago, includes the CBS broadcast television network, Paramount Pictures, and the Nickelodeon channel. Paramount chair, Sherry Redstone, is set to depart the company's board once the Skydance merger is complete. And Tesla shares are on the rise today as the company is reported to launch its robo taxis in San Francisco this weekend. That's according to Insider. Unlike its Austin debut, the robo taxis will use safety drivers seated in the cars. And that's your Yahoo! Finance market minute. Scan the QR code below to track the best and worst performing stocks of the trading session. Related Videos Japan's 'novel' US investment deal faces 'a lot' of questions Palantir highs, Phillips 66 Q2 beat, Comcast's Versant spin-off Question of the day: Are we in a market bubble? What Volkswagen's $1.5B tariff hit means for US expansion Sign in to access your portfolio
Yahoo
15 minutes ago
- Yahoo
Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance
Edwards Lifesciences' (NYSE:EW) stock surged Friday following a strong second-quarter 2025 earnings report that saw the medical device innovator surpass revenue and earnings expectations, driven by significant growth across its heart valve therapies. The strong performance prompted the company to raise its full-year sales guidance, signaling renewed momentum in its core markets. The heart devices company reported sales of $1.53 billion on Thursday after hours, beating the consensus of $1.49 billion and within the management guidance of $1.45 billion-$1.53 billion. Sales grew 11.9% or 10.6% adjusted, with strength across all product groups. Edwards Lifesciences reported adjusted earnings of 67 cents, beating the consensus of 62 cents and the management guidance of 59-65 cents per company reported Transcatheter Aortic Valve Replacement (TAVR) sales of $1.1 billion, marking an increase of 8.9% (or 7.8% on a constant currency basis). The company said that TAVR growth for the quarter surpassed their expectations. Transcatheter Mitral and Tricuspid Therapies (TMTT) segments achieved second-quarter sales of $134.5 million, demonstrating a year-over-year growth of 61.9%, or more than 57.1% on a constant currency basis. In the Surgical segment, second-quarter global sales reached $267 million, an increase of 7.7% over the prior year, or 6.8% on a constant currency basis. Outlook 'We are pleased to report strong second quarter results that delivered double-digit sales growth. Based on our better-than-expected first half performance and the many catalysts across our portfolio, we are confident in our full-year outlook and are raising our sales and EPS guidance,' said Bernard Zovighian, CEO. Edwards Lifesciences raised its 2025 sales guidance from $5.70 billion-$6.10 billion to $5.90 billion-$6.10 billion compared to the consensus of $5.91 billion. The company affirms fiscal 2025 adjusted earnings guidance of $2.40-$2.50 per share compared to the consensus of $2.48. Edwards Lifesciences forecasts third-quarter adjusted earnings of 54-60 cents, compared to the consensus of 60 cents, and sales of $1.46 billion, $1.54 billion versus the consensus of $1.48 billion. View more earnings on EW The company is increasing its underlying growth rate guidance for TAVR to 6% to 7%, driven by strong performance, and its sales guidance range for TAVR to $4.3 billion to $4.5 billion. Sales guidance for TMTT and Surgical product groups remains unchanged. Analyst Insights: Goldman Sachs Goldman Sachs said Friday that the second quarter of 2025 marked a key turning point for the company and reinforced its belief that Edwards is on track to achieve steady double-digit revenue growth again. The firm noted that Edwards' core TAVR business is gaining momentum, even though the quarter only partially reflected the impact of the new asymptomatic indication and included just a small boost from Boston Scientific Corporation's (NYSE:BSX) planned market exit. This gives Goldman confidence that the business will operate at a stronger baseline. Analyst David Roman expects Edwards to get back to its previous strong performance over the next few years, with revenue growing over 10% and operating margins above 30%. With this kind of growth, Goldman Sachs believes the stock deserves a higher valuation, more than 30 times its earnings. The analyst maintains the Buy rating, raising the price forecast from $89 to $101. Other Analysts Several leading financial analysts re-evaluated their outlook on Edwards Lifesciences, with a general trend toward increased price forecasts. Baird has maintained a Neutral rating on the company, slightly increasing its price forecast from $78 to $79. Deutsche Bank, on the other hand, reiterates a Buy rating and has significantly raised its price forecast from $85 to $94. Evercore ISI affirms an In-Line rating, with a modest increase in its price forecast from $77 to $80. Wells Fargo continues to maintain an Overweight rating, raising its price forecast from $80 to $84. Similarly, RBC Capital maintains an Outperform rating, lifting its price forecast from $85 to $89. Piper Sandler also keeps an Overweight rating, increasing its price target from $83 to $90. Barclays maintains an Overweight rating and has raised its price forecast from $90 to $95. Finally, a Stifel analyst has reiterated a Buy rating, also increasing the price forecast from $90 to $95. Price Action: EW stock is trading higher by 4.87% to $79.49 at last check Friday. Read Next:Image via Shutterstock Latest Ratings for EW Date Firm Action From To Feb 2022 UBS Upgrades Neutral Buy Jan 2022 Morgan Stanley Maintains Overweight Jan 2022 Raymond James Maintains Outperform View More Analyst Ratings for EW View the Latest Analyst Ratings UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? EDWARDS LIFESCIENCES (EW): Free Stock Analysis Report This article Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15 minutes ago
- Yahoo
Why Advanced Micro Devices (AMD) Shares Are Climbing Today
Advanced Micro Devices (NASDAQ:AMD) shares climbed about 3% Friday after analysts flagged Intel's (NASDAQ:INTC) ongoing market?share losses to AMD. That's why investor confidence rose on expectations that AMD keeps grabbing business from its larger rival. Warning! GuruFocus has detected 5 Warning Signs with AMD. J.P. Morgan analysts noted Intel's shift toward a more fabless model won't pay off for another 1824 months, leaving AMD to reinforce its position with Ryzen and EPYC platforms. They see sustained momentum in AMD's server?CPU shipments as cloud providers and enterprises favor its cost?efficient designs. Morgan Stanley chimed in, pointing to Intel's margin pressures from startup costs and restructuring charges. That contrast boosts AMD's near?term outlook: its higher gross margins and leaner expense base paint a more resilient picture. Market watchers also highlight AMD's expanding GPU lineup as a secondary growth driver, with generative?AI workloads fueling demand alongside NVIDIA (NASDAQ:NVDA). As Intel grapples with transition costs, AMD stands to pick up share in both PC and data?center markets. With analysts' price targets generally above current levels, AMD's stock rally underscores a broader semiconductor shift, smaller players seizing ground as incumbents navigate costly transformations. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data